Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Myofibrilar Ca2+ sensitivity is regulated by the PKA-mediated phosphorylation of cTnI at Ser22/23, with the phosphorylation of cTnI shown to decrease the Ca2+ sensitivity of the myofilament in normal hearts (63, 64).”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [63]
Citations
Cites
Untersuchungen uber die Harnstoffbildung im Tierkörper
Krebs, H. A., & Henseleit, K. (1932) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1932.210.1-2.33 · Cited by 3,100
Effect of pressure development on oxygen consumption by isolated rat heart
Neely, Liebermeister, H., Battersby, E., & Morgan, H. (1967) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1967.212.4.804 · Cited by 1,094
Regulation of Glucose Uptake in Muscle
Morgan, H. E., Henderson, M. J., Regen, D. M., & Park, C. R. (1961) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64348-0 · Cited by 597
Determination of the complete amino acid sequence of bovine cardiac troponin C
van Eerd, J.-P., & Takahashi, K. (1976) · Biochemistry · doi:10.1021/bi00650a033 · Cited by 252
Syska, H., Wilkinson, J. M., Grand, R. J. A., & PERRY, S. V. (1976) · Biochemical Journal · doi:10.1042/bj1530375 · Cited by 248
Self-citationPhosphorylation of troponin and the effects of interactions between the components of the complex
Perry, S. V., & Cole, H. (1974) · Biochemical Journal · doi:10.1042/bj1410733 · Cited by 230
Self-citationChemical and immunochemical characteristics of tropomyosins from striated and smooth muscle
Cummins, P. L., & PERRY, S. V. (1974) · Biochemical Journal · doi:10.1042/bj1410043 · Cited by 211
Self-citationThe phosphorylation of troponin I from cardiac muscle
Cole, H. A., & Perry, S. V. (1975) · Biochemical Journal · doi:10.1042/bj1490525 · Cited by 151
Self-citationENGLAND, P. J. (1975) · FEBS Letters · doi:10.1016/0014-5793(75)81040-4 · Cited by 148
Syska, H., PERRY, S. V., & Trayer, I. P. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)80238-3 · Cited by 125
Self-citation
Research works printed but not linked: 2
- Grand, R. J. A., Wilkinson, J. M., and Mole, L. E., Biochem. J. (in the press).
- Rubio, R., Bailey, C., and Villar-Palasi, C., J. Cyclic Nucleotide Res., 1, 143–150 (1975).
Cited by
Items 201–300 of 394
Lee, J. A., & Allen, D. G. (1990) · BMJ · doi:10.1136/bmj.300.6724.551 · Cited by 33
Contractile action of levosimendan and epinephrine during acidosis
Toller, W. G., Wölkart, G., Stranz, C., Metzler, H., & Brünner, F. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.11.049 · Cited by 30
“involve troponin C, but could also be due to increased phosphorylation of troponin I following g-adreno stimulation or PDE inhibition ( Solaro et al., 1976; Tavernier et al., 2001).”
BackgroundCardiac sarcoplasmic reticulum chloride channels regulated by protein kinase A.
Kawano, S., Nakamura, F., Tanaka, T., & Hiraoka, M. (1992) · Circulation Research · doi:10.1161/01.res.71.3.585 · Cited by 28
Phosphorylation of a bovine cardiac actin complex
Bailin, G. (1979) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1979.236.1.c41 · Cited by 28
Ezrailson, E. G., POTTER, J., Michael, L., & Schwartz, A. (1977) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(77)80364-7 · Cited by 28
Potentiation of beta-adrenergic inotropic response by pyruvate in failing human myocardium
Hermann, H. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00437-0 · Cited by 27
A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin C
Reinoso, T. R., Landim-Vieira, M., Shi, Y., Johnston, J. R., Chase, P. B., Parvatiyar, M. S., Landstrom, A. P., Pinto, J. R., & Tadros, H. J. J. (2020) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-020-09592-5 · Cited by 27
Guillory, A. N., Yin, X., Wijaya, C. S., Díaz, A. D., Rababa’h, A. M., Singh, S., Atrooz, F., Sadayappan, S., & McConnell, B. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074784 · Cited by 27
“[2,7-9].”
Boontje, N. M., Merkus, D., Zaremba, R., Versteilen, A. M. G., de Waard, M. C., Mearini, G., de Beer, V. J., Carrier, L., Walker, L. A., Niessen, H. W. M., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.12.002 · Cited by 32
“Cardiomyocyte function and phosphorylation levels of the main PKA target proteins, myosin-binding protein-C (cMyBP-C) and troponin I (cTnI) [15–17], were analyzed in small needle biopsies obtained frompigmyocardium before and during dubutamine infusion.”
BackgroundUsing cAMP Sensors to Study Cardiac Nanodomains
Schleicher, K., & Zaccolo, M. (2018) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd5010017 · Cited by 30
“Using patch clamp to measure CNGC-mediated cation currents revealed that β-adrenergic receptors are functionally coupled to nearby Ca2+ channels via local elevations of cAMP [21].”
BackgroundInfluentialGranzier, H., Labeit, D., Wu, Y., & Labeit, S. (2002) · Journal of Muscle Research and Cell Motility · doi:10.1023/a:1023458406346 · Cited by 27
“Thus, in addition to the well-characterized myofibrillar PKA substrates MyBP-C and TnI, titin also contains a PKA-responsive domain expressed only in cardiac muscle.”
BackgroundGranzier, H., Labeit, D., Wu, Y., & Labeit, S. (2003) · Springer eBooks · doi:10.1007/978-94-010-0147-2_7 · Cited by 27
Quirk, P. G., Patchell, V. B., Gao, Y. Z., Levine, B. A., & PERRY, S. V. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00812-n · Cited by 27
Self-citationVikhorev, P. G., Song, W., Wilkinson, R., Copeland, O., Messer, A. E., Ferenczi, M. A., & Marston, S. B. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.10.024 · Cited by 28
“Early studies showed that b-adrenergic stimulation of contraction is associated with enhanced phosphorylation of troponin I (4,5), troponin I is bisphosphorylated at Ser-22 and Ser-23 in the cardiac-specific N-terminal extension by PKA (6–8), and the primary effect of phosphorylation of troponin I in vitro is reduced…”
BackgroundSolis, R. S., Ge, Y., & Walker, J. W. (2011) · Protein Science · doi:10.1002/pro.623 · Cited by 30
“Under the influence of b-adrenergic stimulation, cTnI becomes phosphorylated at Ser22 and Ser23 (also known as Ser23 and Ser24 including initial methionine) by cyclic AMPactivated protein kinase (PKA).(14,16) Phosphorylation of these ‘‘PKA sites’’ in cTnI regulates the Ca2þ sensitivity of force development and MgATPas…”
BackgroundCardiac troponin I inhibitory peptide: location of interaction sites on troponin C
Abbott, M. B., Dvoretsky, A., Gaponenko, V., & Rosevear, P. R. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01271-0 · Cited by 26
Protein phosphorylation in cardiac and vascular smooth muscle
Bárány, M., & Bárány, K. (1981) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1981.241.2.h117 · Cited by 25
ENGLAND, P. J. (1977) · Biochemical Journal · doi:10.1042/bj1680307 · Cited by 25
Warren, C. M., Kobayashi, T., & Solaro, R. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807621200 · Cited by 24
Self-citationBurgoyne, J. R., & Eaton, P. (2010) · Sensors · doi:10.3390/s100402731 · Cited by 27
“This increases the rate of cardiac relaxation by enhancing the rate at which Ca is dissociated from cTnC without effecting maximum actomysoin ATPase activity [86-88].”
BackgroundWalker, J. S., Walker, L. A., Margulies, K., Buttrick, P. M., & de Tombe, P. P. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00838.2010 · Cited by 25
Liu, X., Zhang, L., Pacciulli, D., Zhao, J., Nan, C., Shen, W., Quan, J., Tian, J., & Huang, X. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00629 · Cited by 24
“PKAmediated cTnI phosphorylation causes a decrease of myofibril sensitivity to Ca2+ or a desensitization of the contractile apparatus to activation by Ca2+ (Solaro et al., 1976; Rorbertson et al., 1982; Zhang et al., 1995; Chandra et al., 1997; Solaro, 2001; Metzger and Westfall, 2004; Periasamy and Janssen, 2008).”
BackgroundAdditional PKA phosphorylation sites in human cardiac troponin I
Ward, D. G., Ashton, P. R., Trayer, H. R., & Trayer, I. P. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01871.x · Cited by 27
Sequeira, V., Witjas‐Paalberends, E. R., Kuster, D. W. D., & van der Velden, J. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1400-3 · Cited by 27
“PKA mediates positive inotropic, lusitropic, and chronotropic responses via phosphorylation of a multitude of cellular components including the myofilament proteins troponin I (cTnI) [12, 51], cMyBP-C [14, 18, 28], and titin [68].”
BackgroundXu, F., Xu, Q., Dong, X., Guy, M. J., Güner, H., Hacker, T. A., & Ge, Y. (2010) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2010.09.007 · Cited by 25
Wijnker, P. J. M., Li, Y., Zhang, P., Foster, D. B., dos Remedios, C. G., Eyk, J. E. V., Stienen, G. J. M., Murphy, A. M., & van der Velden, J. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.03.006 · Cited by 25
“Phosphorylation of both sites by PKA, which is activated via the beta-adrenergic receptor pathway during stress and exercise, results in a decreased Ca-sensitivity of force development and thereby improves relaxation of the heart [3–6].”
BackgroundPharmacology of Levosimendan: A New Myofilament Calcium Sensitizer
Pagel, P. S., Haikala, H., Pentikäinen, P. J., Toivonen, M. L., Nieminen, M. S., Lehtonen, L., Papp, J. G., & Warltier, D. C. (1996) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.1996.tb00232.x · Cited by 23
Purification and characterization of phospholamban phosphatase from cardiac muscle.
Kranias, E. G., Steenaart, N. A. E., & Salvo, J. D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37641-0 · Cited by 23
Hydrodynamic properties of bovine cardiac troponin-I and troponin-T.
Byers, D. M., & Kay, C. M. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32812-6 · Cited by 23
Calcium sensitivity and myofilament lattice structure in titin N2B KO mice
Lee, E.-J., Nedrud, J., Schemmel, P., Gotthardt, M., Irving, T. C., & Granzier, H. L. M. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.12.004 · Cited by 23
“The underlying mechanism probably involves known PKA targets in the sarcomere, cTnI[47], cMyBPC[48] and titin[49].”
BackgroundTroponin I modulation of cardiac performance: Plasticity in the survival switch
Biesiadecki, B. J., & Westfall, M. V. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.01.025 · Cited by 25
Hoh, J. F. Y., Rossmanith, G. H., & Hamilton, A. M. (1991) · Circulation Research · doi:10.1161/01.res.68.3.702 · Cited by 22
Timek, T. A., Vahl, C.-F., Bonz, A. W., Schäffer, L., Rosenberg, M., & Hagl, S. (1998) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(98)00764-4 · Cited by 22
Hermann, H., Zeitz, O., Keweloh, B., Hasenfuss, G. P., & Janssen, P. M. L. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.2.h702 · Cited by 22
Rupp, H. (1980) · Basic Research in Cardiology · doi:10.1007/bf01907579 · Cited by 22
Pathomechanisms in heart failure: the contractile connection
Stienen, G. J. M. (2014) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-014-9395-8 · Cited by 23
“…concentrated on the Serine 23/24 sites on cTnI (human sequence) and sites on cTnT because they were substrates for protein kinase A (PKA), and protein kinase C (PKC) activated upon b-and a-adrenergic stimulation, respectively (Solaro et al. 1976; Noland et al. 1989, 1995; Mittmann et al. 1992).”
Backgroundde Tombe, P. P., Burkhoff, D., & Hunter, W. C. (1992) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(92)91093-k · Cited by 24
A Revised Perspective on the Evolution of Troponin I and Troponin T Gene Families in Vertebrates
Joyce, W., Ripley, D. M., Gillis, T. E., Black, A. C., Shiels, H. A., & Hoffmann, F. G. (2022) · Genome Biology and Evolution · doi:10.1093/gbe/evac173 · Cited by 26
“…serine residues that, when phosphorylated via ß-adrenergic stimulation, decrease myofilament Ca2+ sensitivity (Fentzke et al. 1999; Layland et al. 2005; Robertson et al. 1982; Solaro et al. 1976), thereby increasing the rate of relaxation during diastole (Kentish et al. 2001; Zhang et al. 1995).”
BackgroundRegulation of myocardial contraction as revealed by intracellular Ca2+ measurements using aequorin
Kurihara, S., & Fukuda, N. (2024) · The Journal of Physiological Sciences · doi:10.1186/s12576-024-00906-7 · Cited by 21
“To our knowledge, this was the first clear demonstration of the Ca 2 + -desensitizing effect of PKA-dependent phosphorylation of TnI, first reported by Solaro et al. [65], in intact myocardial preparations.”
BackgroundDiscovery of Phospholamban: A Personal History
Katz, A. M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08252.x · Cited by 20
Cardiac function and phosphorylation of contractile proteins
ENGLAND, P. J. (1983) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.1983.0040 · Cited by 20
Pavadai, E., Rynkiewicz, M. J., Yang, Z., Gould, I. R., Marston, S. B., & Lehman, W. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109282 · Cited by 19
Cai, W., Hite, Z. L., Lyu, B., Wu, Z., Lin, Z., Gregorich, Z. R., Messer, A. E., McIlwain, S. J., Marston, S. B., Kohmoto, T., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.07.247 · Cited by 19
Solaro, C. R., & Solaro, R. J. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.05.010 · Cited by 21
“A major difference between cardiac and skeletal isoforms is the presence of an N-terminal extension in cTnI consisting of ~30 amino acids with sites of phosphorylation by protein kinase A [5].”
Self-citationMorjana, N. A., & Tal, R. (1998) · Biotechnology and Applied Biochemistry · doi:10.1111/j.1470-8744.1998.tb00506.x · Cited by 19
Malhotra, A., Nakouzi, A. S., Bowman, J. C., & Buttrick, P. M. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006865600519 · Cited by 19
“Putative PKA phosphorylation sites are located at the ser22 and ser-23 residues in the amino terminal portion of the cardiac troponin I molecule [8] and studies in which a mutant TnI with no amino terminal extension was used for reassociation experiments, demonstrated that phosphorylation of TnI by PKA is both necessa…”
BackgroundCholinergic regulation of calcium sensitivity in cardiac muscle
Horowits, R., & Winegrad, S. (1983) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(83)90282-1 · Cited by 19
Clinical Biochemistry of Serum Troponin
Gokhan, I., Dong, W., Grubman, D., Mezue, K. N., Yang, D. H., Wang, Y., Gandhi, P. U., Kwan, J. M., & Hu, J. (2024) · Diagnostics · doi:10.3390/diagnostics14040378 · Cited by 26
Dong, W., An, J., Xing, J. W., & Cheung, H. C. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.08.007 · Cited by 18
Moir, A. J. G., & PERRY, S. V. (1980) · Biochemical Journal · doi:10.1042/bj1910547 · Cited by 18
Self-citationWhere is the origin of the activator calcium in cardiac ventricular contraction?
Reiter, M., Vierling, W., & Seibel, K. (1984) · Basic Research in Cardiology · doi:10.1007/bf01935801 · Cited by 18
Chen, G., Zhou, X., Nicolaou, P. A., Rodríguez, P., Song, G., Mitton, B. A., Pathak, A. B., Zachariah, A., Fan, G., Dorn, G. W., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-097428 · Cited by 17
“cellular targets, such as PLN, and concomitantly reduced cardiac contractility (7, 18).”
BackgroundKonhilas, J. P., Irving, T. C., Wolska, B. M., Jweied, E. E., Martin, A. F., Solaro, R. J., & de Tombe, P. P. (2003) · The Journal of Physiology · doi:10.1111/j.1469-7793.2003.00951.x · Cited by 17
“It is well established that phosphorylation of the cardiac sarcomere mediated by protein kinase A (PKA) induces a reduction in myofilament Ca2+ sensitivity (Solaro et al. 1976; de Tombe & Stienen, 1995; Janssen & de Tombe, 1997), an observation that was confirmed in the present study.”
BackgroundInfluentialSelf-citationRole of regulatory proteins (troponin-tropomyosin) in pathologic states
Malhotra, A. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00925959 · Cited by 19
“It has been demonstrated that the pH sensitivity in cardiac myofibrils and expression of cardiac Tn] are influenced by developmental stage and hormonal status [ 74 , 75].”
BackgroundSevrieva, I. R., Ponnam, S., Yan, Z., Irving, M., Kampourakis, T., & Sun, Y. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102767 · Cited by 19
Sequeira, V., Waddingham, M. T., Tsuchimochi, H., Maack, C., & Pearson, J. T. (2023) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2023.100036 · Cited by 28
“PKA-mediated phosphorylation of Ca 2+ handling proteins, including phospho-lamban, as well as myo fi lament proteins cTnI (cardiac troponin I) [56,57] and cMyBP-C [58,59], modulate inotropic, lusitropic, and chronotropic responses, ultimately regulating myocardial contractility.”
Wijnker, P. J. M., Sequeira, V., Witjas‐Paalberends, E. R., Foster, D. B., dos Remedios, C. G., Murphy, A. M., Stienen, G. J. M., & van der Velden, J. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.04.017 · Cited by 16
Pimobendan directly sensitizes reconstituted thin filament to slide on cardiac myosin
Sata, M., Sugiura, S., Yamashita, H., Aoyagi, T., Momomura, S., & Serizawa, T. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)90016-0 · Cited by 16
Catecholamine-induced phosphorylation of cardiac muscle proteins
Dobson, J. G. (1981) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(81)90077-5 · Cited by 16
Cottney, J. E., Logan, R., Marshall, R., Nicholson, D., Shahid, M., & Walker, G. (1990) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.1990.tb00392.x · Cited by 16
Regulation of Carbohydrate Metabolism by Cyclic Nucleotides
Exton, J. H. (1982) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-68393-0_1 · Cited by 17
Gresham, K. S., Mamidi, R., Li, J., Kwak, H., & Stelzer, J. E. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00306.2016 · Cited by 15
“In response to -adrenergic stimulation, PKA-mediated phosphorylation of TnI reduces the affinity of TnC to Ca(2) and decreases thin-filament Ca(2) sensitivity of force generation (15, 47), resulting in accelerated thin-filament deactivation that speeds myocardial relaxation.”
BackgroundWhat We Know and Do Not Know about Sex and Cardiac Disease
Konhilas, J. P. (2010) · BioMed Research International · doi:10.1155/2010/562051 · Cited by 18
“targeting Ca2+ cycling machinery, phospholamban, leading to enhanced reuptake of Ca2+ by the sarcoplasmic reticulum [79–82] and direct phosphorylation of contractile proteins, troponin I, and myosin binding protein C [87, 88] to alter contractile mechanics.”
BackgroundLowenthal, M. S., Gasca-Aragon, H., Schiel, J. E., Dodder, N. G., & Bunk, D. M. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.07.037 · Cited by 15
Dávila, A. J. L., Zhu, L., Fritz, L., Kraft, T., & Chalovich, J. M. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00499 · Cited by 15
Troponin I: Inhibitor or facilitator
Perry, S. V. (1999) · Springer eBooks · doi:10.1007/978-1-4615-5543-8_2 · Cited by 15
Self-citationResink, T. J., & Gevers, W. (1981) · Cell Calcium · doi:10.1016/0143-4160(81)90049-x · Cited by 15
Phospholipid-Sensitive Ca2+-Dependent Protein Phosphorylation
Schatzman, R. C., Turner, R. S., & Kuo, J. F. (1984) · Elsevier eBooks · doi:10.1016/b978-0-12-171405-5.50009-2 · Cited by 15
Varshney, R., Ranjit, R., Chiao, Y. A., Kinter, M. T., & Ahn, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042039 · Cited by 16
“Cardiac troponin I and troponin C also have different amino acid sequences from their skeletal muscle counterparts [43].”
BackgroundLKB1/Mo25/STRAD Uniquely Impacts Sarcomeric Contractile Function and Posttranslational Modification
Behunin, S. M., Lopez‐Pier, M. A., Birch, C. L., McKee, L. A. K., Danilo, C., Khalpey, Z. I., & Konhilas, J. P. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.02.012 · Cited by 15
Seppet, E. K., Kaasik, A., Minajeva, A., Paju, K., Ohisalo, J. J., Vetter, R., & Braun, U. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5653-4_29 · Cited by 14
Some characteristics of Ca2+- regulated force production in EGTA-treated muscles from rat heart.
Kentish, J. C., & Jewell, B. R. (1984) · The Journal of General Physiology · doi:10.1085/jgp.84.1.83 · Cited by 14
Rosas, P. C., & Solaro, R. J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1060716 · Cited by 17
“Phosphorylation of these sites reduces myofilament Ca-sensitivity and enhances relaxation (51, 52).”
BackgroundSelf-citationDysferlin deficiency blunts β‐adrenergic‐dependent lusitropic function of mouse heart
Wei, B., Wei, H., & Jin, J. (2015) · The Journal of Physiology · doi:10.1113/jp271225 · Cited by 13
“…primary mechanism regulating cardiac muscle contractility is the phosphorylation of various thin and thick filament proteins, including cardiac TnI (Solaro et al. 1976; Moir & Perry, 1980; Garvey et al. 1988; Zhang et al. 1995), MyBP-C (Garvey et al. 1988; Gautel et al. 1995; Weisberg & Winegrad,…”
BackgroundTargeted proteomics of myofilament phosphorylation and other protein posttranslational modifications
Ramirez‐Correa, G. A., Martinez‐Ferrando, M. I., Zhang, P., & Murphy, A. M. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400034 · Cited by 13
“Modulation of myofilament function by rapid phosphorylation in response to a physiological neurohumoral stimulus was first demonstrated 38 years ago for cardiac troponin I (cTnI) [13].”
BackgroundThin Filament Changes during In Vivo Rat Heart Development
L’Ecuyer, T. J., Schulte, D., & Lin, J. J.-C. (1991) · Pediatric Research · doi:10.1203/00006450-199109000-00006 · Cited by 13
Henze, M., Patrick, S. E., Hinken, A. C., Scruggs, S. B., Goldspink, P. H., de Tombe, P. P., Kobayashi, M., Ping, P., Kobayashi, T., & Solaro, R. J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.012 · Cited by 13
“Unique domains, especially the cTnI N-terminus consisting of ~30 amino acids are well known to control cardiac function [3-6].”
Self-citationMamidi, R., Gollapudi, S. K., Mallampalli, S. L., & Chandra, M. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.05.024 · Cited by 12
The neglected messengers: Control of cardiac myofilaments by protein phosphatases
Lorenzen‐Schmidt, I., Clarke, S. B., & Pyle, W. G. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.10.002 · Cited by 16
Pathophysiology of heart failure and an overview of therapies
Ranek, M. J., Berthiaume, J. M., Kirk, J. A., Lyon, R. C., Sheikh, F., Jensen, B. C., Hoit, B. D., BUTANY, J. W., Tolend, M., Rao, V. A., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822224-9.00025-6 · Cited by 20
Gillis, T. E., Klaiman, J. M., Foster, A., Platt, M. J., Huber, J. S., Corso, M. Y., & Simpson, J. A. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00773.2015 · Cited by 18
“The role of myofilament protein phosphorylation in regulating muscle function has been extensively studied in cardiac muscle (27, 32, 41, 52); however, much less is known of the role of protein phosphorylation in modulating the function of skeletal muscle (14).”
BackgroundOnishi, J., Browne, V. A., Kono, S., Stiffel, V. M., & Gilbert, R. D. (2003) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2003.07.003 · Cited by 13
Kopp, S. J., & Bárány, M. (1980) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(80)90214-8 · Cited by 12
Control and Modulation of Contractile Activity of Cardiac Myofilaments
Solaro, R. J., & Pan, B. (1989) · Developments in cardiovascular medicine · doi:10.1007/978-1-4613-0873-7_14 · Cited by 14
Self-citationSmall molecule studies: the fourth wave of muscle research
Marston, S. B. (2019) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-019-09526-w · Cited by 11
Molecular Regulation of Phospholamban Function and Gene Expressiona
Tada, M., YABUKI, M., & Toyofuku, T. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08261.x · Cited by 11
Protein kinase G signaling in cardiac pathophysiology: Impact of proteomics on clinical trials
Kirk, J. A., Holewinski, R. J., Crowgey, E. L., & Eyk, J. E. V. (2015) · PROTEOMICS · doi:10.1002/pmic.201500401 · Cited by 13
“Protein kinase A (PKA) sites on cardiac troponin I (TnI), the inhibitory protein that stops muscle contraction, have been known for almost half a century [49], but it was discovered only recently that these same sites (S22/S23) could be targeted by PKG as well.”
BackgroundA comparative study of the cardiac troponin inhibitory factor (TNI) from mammalians
Berson, G., Samuel, J., & Bernard Swynghedauw, A. (1978) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00585605 · Cited by 11
Membrane control of cardiac contractility
McClellan, G. B., & Winegrad, S. (1977) · Nature · doi:10.1038/268261a0 · Cited by 11
Cyclic AMP-Dependent Activation of Protein Kinases in the Myocardium
Dobson, J. G. (1981) · Springer eBooks · doi:10.1007/978-3-642-68321-3_12 · Cited by 11
Greenman, A., Diffee, G. M., Power, A., WILKINS, G. T., Gold, O. M. S., Erickson, J. R., & Baldi, J. C. (2021) · Experimental Physiology · doi:10.1113/ep089730 · Cited by 12
“Post-translational phosphorylation ofmyofilament proteins, particularly cardiac troponin I (cTnI) (Solaro & Kobayashi, 2011; Solaro et al., 1976) and cardiac myosin binding protein C (cMyBP-C) (Winegrad Saul, 1999) alter the calcium sensitivity of force (pCa50) in ‘skinned’ (permeatedmembrane)…”
BackgroundRasmussen, M. A., Feng, H., & Jin, J. (2021) · Journal of Molecular Evolution · doi:10.1007/s00239-021-10039-9 · Cited by 9
Marston, S. B. (2022) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-022-09630-4 · Cited by 10
“It is well established that phosphorylation of troponin is essential for lusitropy (Ray and England, 1976; Solaro et al., 1976; Layland et al., 2005).”
BackgroundOnishi, J., Kamitomo, M., Stiffel, V. M., & Gilbert, R. D. (2003) · Journal of the Society for Gynecologic Investigation · doi:10.1016/s1071-5576(03)00042-x · Cited by 11
“5) with or without the PKA inhibitor PKI(6-22) and placed in a test tube.”
BackgroundGunther, L. K., Feng, H., Wei, H., Raupp, J. J., Jin, J., & Sakamoto, T. (2016) · Biochemistry · doi:10.1021/acs.biochem.5b01059 · Cited by 10
Phosphorylation of the myofibrillar proteins and the regulation of contractile activity in muscle
Perry, S. V. (1983) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.1983.0038 · Cited by 10
Self-citationCyclic Nucleotides and the Heart
Nayler, W. G. (1977) · Advances in Drug Research · doi:10.1016/b978-0-12-013312-3.50005-4 · Cited by 10
Ford, S. J., & Chandra, M. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.240085 · Cited by 9
“On the other hand, switching to the cTnI isoform is advantageous to adult cardiomyocytes because this isoform contains two key phosphorylation sites, Ser23 and Ser24 (Solaro et al. 1976; Mittmann et al. 1990).”
BackgroundPathophysiology of Heart Failure and an Overview of Therapies
Berthiaume, J. M., Kirk, J. A., Ranek, M. J., Lyon, R. C., Sheikh, F., Jensen, B. C., Hoit, B. D., BUTANY, J. W., Tolend, M., Rao, V. A., et al. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420219-1.00008-2 · Cited by 16
Donck, L. V. (1996) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.1996.tb00226.x · Cited by 9
Metadata
- Authors
- SOLARO, R. J., MOIR, A. J. G., & PERRY, S. V.
- Affiliations
- University of Birmingham (GB)
- ORCID
- SOLARO, R. J.
- Venue
- Nature
- Published
- 1976-08
- Volume
- 262
- Issue
- 5569
- Pages
- 615-617
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2045141838
- Cited by
- 395
- References
- 13
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 11 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 6 · 2017: 5 · 2016: 11 · 2015: 13 · 2014: 14 · 2013: 9 · 2012: 10
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- troponin I phosphorylation, epinephrine, inotropic effect, cardiac contractility, troponin complex, tropomyosin, troponin C, troponin T, intracellular calcium, myocardium
- MeSH terms
- Animals, Epinephrine, Muscle Proteins, Myocardial Contraction, Myocardium, Phosphates, Protein Kinases, Rabbits, Troponin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.